Replies to post #431064 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Do not have a link, but one of the quoted posters from the Specials programs said something along the lines that there was an initial fee and then add-ons for the doses after 1 year(?).

That would be reasonable. Need to somehow blend the reality of manufacturing cost being al up-front while patient benifit being over time.

That said, nobody (not even LP) knows what it would price at.

[Chiugray]

Here's a 2014 article that discusses the DCVax-L drug price, seemingly from an interview with Linda Powers. Of course no definitive price is stated, just pieces of the puzzle.

From this, I can see how a $150K drug price, that is used by many on Ihub, can be derived. My vision of a scenario is:
- Maybe 9 to 12 total injections
- Yr 1: 5-8 injections, $100K price
- Yr 2: booster 2 injections, $25K price
- Yr 3: booster 2 injections, $25K price
Total $150K

DCVax-L initially could be priced higher than Temodar, which costs about $65,000 to $70,000 a year. Powers said the price for DCVax-L was warranted because of signs of effectiveness seen in the informal early-stage trials

https://www.reuters.com/article/us-northwestbiotherapeutics-cancer-idUSBREA290KA20140310

[sentiment_stocks]

Not this time. We’ll have to wait and see how it unfolds. I think, though, that specials patients, and later insurance companies would find this arrangement more appealing. Would you agree with that, or not?